Lv1
60 积分 2026-03-23 加入
A First-in-Human, Phase 1, Multicenter, Open-label, Dose-Escalation Study of PCA062, an Antibody-Drug Conjugate Targeting P-Cadherin, in Patients with Solid Tumors
9天前
已完结
Strategy for streamlining antibody–drug conjugate pharmacokinetic assays
3个月前
已完结
Re-Evaluating Antibody–Drug Conjugate Linker Stability: Assessment, Interpretation, and Clinical Translation
3个月前
已完结
皖公网安备34019202002308
